RECURRENT ISLET CELL CARCINOMA

Clinical trials for RECURRENT ISLET CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT ISLET CELL CARCINOMA trials appear

Sign up with your email to follow new studies for RECURRENT ISLET CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo trial for rare pancreatic cancers

Disease control Ongoing

This study is testing two chemotherapy approaches for people with advanced pancreatic neuroendocrine tumors that have progressed. Researchers want to see if adding the drug capecitabine to temozolomide works better than temozolomide alone at controlling tumor growth. The trial in…

Matched conditions: RECURRENT ISLET CELL CARCINOMA

Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

RECURRENT ISLET CELL CARCINOMA

Get alerted when new RECURRENT ISLET CELL CARCINOMA trials appear

New drug combo trial for rare pancreatic cancers